Abstract: This invention relates to a cationically and amphiphilically modified polygalactomannan having repeating units with an average D-mannosyl to D-galactosyl residue ratio of at least 5 to 1 and to compositions containing same. A portion of the hydrogen atoms of hydroxyl groups situated on the mannosyl and galactosyl residues of the galactomannan are replaced with an amphiphilic and a cationic substituent.

Abstract: This invention related to a cationically and hydrophilically modified polygalactomannan having repeating units with an average D-mannosyl to D-galactosyl residue ratio of at least 5 to 1 and to compositions containing the same. A portion of the hydrogen atoms of hydroxyl groups situated on the mannosyl and galactosyl residues of the galactomannan are replaced with a hydrophilic and a cationic substituent.

Abstract: This invention relates to a cationically and amphiphilically modified polygalactomannan having repeating units with an average D-mannosyl to D-galactosyl residue ratio of at least 5 to 1 and to compositions containing same. A portion of the hydrogen atoms of hydroxyl groups situated on the mannosyl and galactosyl residues of the galactomannan are replaced with an amphiphilic and a cationic substituent.

Abstract: The present invention generally relates to blends that contain alkoxylated, lipophilic polyol compounds having about three moles of lipophilic, substituents per mole of polyol which are polyethylene glycol methyl glucose trioleate and polyethylene glycol methyl glucose dioleate and, more specifically, to the use of such compounds as thickeners in liquid surfactant compositions.

Abstract: The present invention generally relates to blends that contain alkoxylated, lipophilic polyol compounds having about three moles of lipophilic, substituents per mole of polyol which are polyethylene glycol methyl glucose trioleate and polyethylene glycol methyl glucose dioleate and, more specifically, to the use of such compounds as thickeners in liquid surfactant compositions.

Abstract: This invention relates to a cationically and hydrophobically modified polygalactomannan having repeating units with a D-mannosyl to D-galactosyl residue ratio of at least 5 to 1 and to compositions containing same. A portion of the hydrogen atoms of hydroxyl groups situated on the mannosyl and galactosyl residues of the galactomannan are replaced with a hydrophobic substituent and a cationic substituent.

Abstract: This invention related to a cationically and hydrophilically modified polygalactomannan having repeating units with an average D-mannosyl to D-galactosyl residue ratio of at least 5 to 1 and to compositions containing the same. A portion of the hydrogen atoms of hydroxyl groups situated on the mannosyl and galactosyl residues of the galactomannan are replaced with a hydrophilic and a cationic substituent.

Abstract: Microencapsulated delivery vehicles comprising an active agent are disclosed. In one embodiment, the microencapsulated delivery vehicles are heat delivery vehicles capable of generating heat upon activation. The microencapsulated heat delivery vehicles may be introduced into wet wipes such that, upon activation, the wet wipe solution is warmed resulting in a warm sensation on a user's skin. Any number of other active ingredients, such as cooling agents and biocides, can also be incorporated into a microencapsulated delivery vehicle.

Abstract: A toilet training article in the form of a toilet training pad containing an effervescent agent is disclosed. The toilet training pad, which may be an insertable pad or integrated directly into an undergarment, contains an effervescent agent which releases gas upon being contacted by urine. The effervescent agent may be in the form of a compound containing a substantially inert gas, or may be a combination of compounds that, upon being contacted by urine, produce a gas.

Abstract: Aqueous liquid cleanser compositions are disclosed. The cleanser compositions are structured liquids capable of suspending a skin benefit agent therein to improve transfer of the skin benefit agent to the skin upon use of the wash. In one embodiment, the skin benefit agent is a lipid material, which remains on the skin after washing to provide skin barrier enhancement.

Abstract: The present invention is generally directed to moisturizing and lubricating compositions for use on the bodyfacing surface of an absorbent product or on one or both faces of a tissue product. The moisturizing and lubricating compositions comprise an emollient, a humectant, and immobilizing agent and a compatibilizing agent. Optionally, the moisturizing and lubricating compositions can comprise a dispersing agent.

Abstract: Topical ointment for preventing and treating diaper rash are disclosed. The topical ointments comprise an emollient, a structurant, a rheology enhancer, and other optional components. In one preferred embodiment, the topical ointment comprises a particulate material such as zinc oxide as an optional component.

Abstract: Tissue products, such as bath tissue and facial tissue, comprising an improved lubricating formulation are disclosed. The lubricating formulation is applied to at least one surface of the tissue product and is stable at elevated temperatures, remains on or near the surface of the tissue product prior to use, and readily transfer the user=s skin upon use. The lubricating formulations described herein have a melt point viscosity of from about 5000 cPs to about 1,000,000 cps, and a process temperature viscosity of from about 50 cPs to about 50,000 cPs. The lubricating formulations comprise an emollient, a structurant, a rheology enhancer, and other optional components.

Abstract: Microencapsulated delivery vehicles comprising an active agent are disclosed. In one embodiment, the microencapsulated delivery vehicles are heat delivery vehicles capable of generating heat upon activation. The microencapsulated heat delivery vehicles may be introduced into wet wipes such that, upon activation, the wet wipe solution is warmed resulting in a warm sensation on a user's skin. Any number of other active ingredients, such as cooling agents and biocides, can also be incorporated into a microencapsulated delivery vehicle.

Abstract: Microencapsulated delivery vehicles comprising an active agent are disclosed. In one embodiment, the microencapsulated delivery vehicles are heat delivery vehicles capable of generating heat upon activation. The microencapsulated heat delivery vehicles may be introduced into wet wipes such that, upon activation, the wet wipe solution is warmed resulting in a warm sensation on a user's skin. Any number of other active ingredients, such as cooling agents and biocides, can also be incorporated into a microencapsulated delivery vehicle.

Abstract: The present invention discloses tissue products comprising a cleansing composition. The cleansing composition removes soil and contaminants from the skin's surface and comprises a thermoplastic polymer and a water soluble neutral oligosaccharide. In one embodiment, the cleansing composition comprises polymethylmethacrylate and a water soluble starch.

Abstract: Cleansing wipes comprising a film forming polymeric material and a cleansing agent stored in dry form are disclosed. The cleansing wipes are water disintegratable such that upon contact with water, the cleansing wipes release the cleansing agent and begin to dissolve/disperse into the water. Full dissolution/dispersion of the cleansing wipes occurs in about 60 seconds or less after contact with water to allow for a sufficient time for cleansing of the hands or other skin area.

Abstract: Novel liquid cleansing products are disclosed. The cleansing products are comprised of a first colored structured liquid and a second colored structured liquid that when dispensed from a suitable dispenser, mix together to form a new colored cleansing product prior to, and during, use.

Abstract: Microencapsulated delivery vehicles comprising an active agent are disclosed. In one embodiment, the microencapsulated delivery vehicles are heat delivery vehicles capable of generating heat upon activation. The microencapsulated heat delivery vehicles may be introduced into wet wipes such that, upon activation, the wet wipe solution is warmed resulting in a warm sensation on a user's skin. Any number of other active ingredients, such as cooling agents and biocides, can also be incorporated into a microencapsulated delivery vehicle.

Abstract: A soothing anti-viral lotion composition and a lotioned tissue product having a surface with the lotion composition applied thereto, and methods for making and using the same. The lotion composition includes an anti-viral organic acid and a topical delivery system. The topical delivery system includes one or more polyesters which allow incorporation of the organic acids into the lotion formulation, controls their delivery, and maintains them in the stratum corneum. The lotion composition may optionally contain a surfactant, an irritation inhibiting agent, and other additives.